Market Overview

Aegerion Pharmaceuticals (AEGR) Leaps as Product OK'd In Japan


Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) rose 22.5% to $3.05 as the company disclosed that its JUXTAPID capsules have been approved in Japan for the treatment of homozygous familial hypercholesterolemia. Share volume was 3.6 million, more than 10 times its all-day average